Microbot Q3 Revenue Collapses to $72K, Missing Estimates by 87%
MBOT is trading near its 52-week low of $0.93 (4.3% above the low).
Summary
Microbot posted Q3 revenue of just $72,000 against a $562,500 analyst consensus — a wide miss — while the adjusted loss of 9 cents a share came in a penny worse than the 8-cent estimate. The quarterly net loss was $5.84 million, inflated by an $815,000 inventory write-down, and revenue fell from $241,000 in Q2. Cash and marketable securities of $61.8 million remain the main support for the story, but the top line shows the LIBERTY robot commercialization is barely generating sales despite the recent distribution and customer announcements. Shares are near the 52-week low at $0.97 and down 48.5% year to date. The December 14 annual meeting includes a request to add 1,000,000 shares to the equity plan, which matters for dilution.
At the time of this announcement, MBOT was trading at $0.97 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $65.7M. The 52-week trading range was $0.93 to $2.86. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.